I am an associate professor in LSHTM’s Clinical Research Department and the lead scientist of the LSHTM Global Health Analytics Group. Originally trained as a laboratory scientist, the majority of my work is now highly multi-disciplinary, involving bench, field and computer based research.

My team of epidemiologists, laboratory researchers and data scientists aim to leverage emerging technology for the benefit of human health. Our current focus-points are on the development of electronic data systems for use in emergencies and epidemics, scalable low-cost laboratory diagnostics and methods for integrated surveillance of infectious diseases. Through funding from the NIHR and DHSC, my group has recently been providing data collection and real time analytics support to two major evaluations of Ebola vaccines in DR Congo.

I am the principal investigator of the NIHR funded Emergency and Epidemic Data Kit project, which won the 2018 LSHTM Director's Award for Best Research Group and the 2017 LSHTM Director's Award for innovation in teaching and learning and to the taught experience. Since 2018, the EDK project team has worked closely with the WHO to control Ebolavirus in DR Congo, work that has led to the first licensure of an effective vaccine against Ebola. More recently we have worked with the WHO to study vaccines and therapeutics targeted against SARS-CoV2

I am a co-investigator and senior data coordinator on the flagship "Tujiokowe" (DRC-EB-001) trial, a major evaluation of Janssen pharmaceuticals' heterologous two dose ebola vaccine, which is funded by a £22m grant from CEPI.

I am a co-investigator and lead two work-packages on FIEBRE, a £10m DfID funded study on the causes of fever in Low and Middle Income Countries (LMICs). I am also the principal investigator of the lab based Mos-Def study, a sister study to FIEBRE which is funded by a £360,000 grant from The Global Good Fund.

I previously led a major programme of research in to the epidemiology of trachoma in the Western Pacific Region, research that was funded by more than £800,000 in grants from the International Trachoma Initiative, Fred Hollows Foundation and Coalition for Operational Research on NTDs (COR-NTD).